Characterisation of HIV-1 Gag Cytotoxic T-Lymphocyte Epitopes in the Southern African Region-A Systematic Review.

ImmunologyMay 31, 2026 (epub)
Clinical ResearchInfectious DiseasesOpen access

Tumelo L Fortuin, Paballo Nkone, Shayne Loubser et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review examined HIV-1 Gag cytotoxic T-lymphocyte (CTL) epitopes in the southern African region, focusing on subtype C. A total of 49 studies were included, identifying 60 Gag CTL epitopes, predominantly in the Gag p24 protein. Notably, the immunodominant epitopes TPQDLNTML and TSTLQEQIGW were found at 16.00% and 13.3%, respectively.

Key findings

  • 60 Gag CTL epitopes were identified, with 55.00% located in the capsid protein (p24).
  • The most common immunodominant epitopes were TPQDLNTML (16.00%) and TSTLQEQIGW (13.3%).
  • HLA-B allotypes accounted for 78% of the CTL responses, with HLA-B*57 and HLA-B*58:01 being notable.
  • Some identified CTL epitopes are not listed in the Los Alamos HIV database.

Why it matters

Understanding the specific CTL epitopes and HLA allotypes that influence HIV-1 control can inform vaccine development strategies, particularly in regions where subtype C is prevalent, potentially improving patient outcomes.

Source

Published in Immunology. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.